欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/H/0104/001
药品名称UFT HARD CAPSULES
活性成分
    • tegafur 100.0 mg
    • uracil 224.0 mg
剂型Capsule, hard
上市许可持有人Bristol Myers Squibb, S.L. Almansa, 101 28040 Madrid Spain New MAH: Merck Farma y Química, S.A.
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • Ireland (IE)
    • Austria (AT)
      Uft 100 mg/224 mg - Kapseln
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
许可日期2000/10/27
最近更新日期2017/09/19
药物ATC编码
    • L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    • L01 ANTINEOPLASTIC AGENTS
    • L01B ANTIMETABOLITES
    • L01BC Pyrimidine analogues
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase